Back to User profile » Dr Tomoko Yamagishi

Papers published by Dr Tomoko Yamagishi:

Original Research

Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17

Yamane H, Ochi N, Nagasaki Y, Yamagishi T, Honda Y, Nakagawa N, Takeyama M, Nakanishi H, Takigawa N

Therapeutics and Clinical Risk Management 2018, 14:1457-1465

Published Date: 21 August 2018

Original Research

Circulating thymus and activation-regulated chemokine/CC chemokine ligand 17 is a strong candidate diagnostic marker for interstitial lung disease in patients with malignant tumors: a result from a pilot study

Yamane H, Ochi N, Yamagishi T, Honda Y, Takeyama M, Takigawa N

Therapeutics and Clinical Risk Management 2015, 11:949-959

Published Date: 17 June 2015

Case report

Docetaxel for non small cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation

Yamane H, Ochi N, Yasugi M, Tabayashi T, Yamagishi T, Monobe Y, Hisamoto A, Kiura K, Takigawa N

OncoTargets and Therapy 2013, 6:155-160

Published Date: 6 March 2013